Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
767,668
Value
$35.7M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SUPN by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026767,668$35.7M<0.1%+145,218+23.3%AddedHolders
Q1 2026622,450$32.2M<0.1%−85,532−12.1%ReducedHolders
Q4 2025707,982$35.2M<0.1%−271,622−27.7%ReducedHolders
Q3 2025979,604$46.8M<0.1%+380,983+63.6%AddedHolders
Q2 2025598,621$18.9M<0.1%+130,740+27.9%AddedHolders
Q1 2025467,881$15.3M<0.1%−77,777−14.3%ReducedHolders
Q4 2024545,658$19.7M<0.1%+136,870+33.5%AddedHolders
Q3 2024408,788$12.7M<0.1%+117,991+40.6%AddedHolders
Q2 2024290,797$7.78M<0.1%+160,431+123.1%AddedHolders
Q1 2024130,366$4.45M<0.1%+1,213+0.9%AddedHolders
Q4 2023129,153$3.74M<0.1%+104,130+416.1%AddedHolders
Q3 202325,023$689.9K<0.1%+523+2.1%AddedHolders
Q2 202324,500$736.5K<0.1%−4,776−16.3%ReducedHolders
Q1 202329,276$1.06M<0.1%−77−0.3%ReducedHolders
Q4 202229,353$1.05M<0.1%+2,153+7.9%AddedHolders
Q3 202227,200$921.0K<0.1%+11,100+68.9%AddedHolders
Q2 202216,100$466.0K<0.1%+8,360+108.0%AddedHolders
Q1 20227,740$250.0K<0.1%+7,740NewHolders
Q3 20210$00.0%−9,923−100.0%Sold outHolders
Q2 20219,923$306.0K<0.1%−4,841−32.8%ReducedHolders
Q1 202114,764$387.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.